Thousands of people living with multiple sclerosis (MS) in England are set to benefit from a new twice-daily pill that significantly improves walking ability, which is now being rolled out on the NHS.
Hailed as "life-changing," fampridine marks a significant advancement as the first drug specifically designed to address walking difficulties associated with the incurable autoimmune disease.
